Shares of Amgen are on an upswing after winning a patent battle over its drug Enbrel against Novartis subsidiary Sandoz. Is it time to buy shares of the massive biotech company?

source https://finance.yahoo.com/m/07810c41-4ed6-3093-b24c-405744e1e01e/amgen-stock-is-the-biggest.html?.tsrc=rss